Showing results (91-100 of 181) with videos related to

Sort By:
Pageof 19
Journal of Chromatography. B, Biomedical Sciences and Applications|October 24, 2000
Simple and selective determination of the cyclophosphamide metabolite phosphoramide mustard in human plasma using high-performance liquid chromatographyA D Huitema, M M Tibben, T Kerbusch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantation incorporating carboplatin, cyclophosphamide and thiotepaS Rodenhuis, J W Baars, J H Schornagel, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|December 30, 1998
Determination of N,N',N"-triethylenethiophosphoramide and its active metabolite N,N',N"-triethylenephosphoramide in plasma and urine using capillary gas chromatographyR J van Maanen, R D van Ooijen, J W Zwikker, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1994
Catheter-related complications in 52 patients treated with continuous infusion of low dose recombinant interleukin-2 via an implanted central venous catheterL T Vlasveld, S Rodenhuis, E J Rutgers, et al.
Bone Marrow Transplantation|October 31, 2002
Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapyM E de Jonge, R A A Mathôt, O Dalesio, et al.
British Journal of Cancer|February 6, 2003
Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcomeI F Faneyte, J G Schrama, J L Peterse, et al.
The New England Journal of Medicine|October 8, 1987
Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lungS Rodenhuis, M L van de Wetering, W J Mooi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
The pharmacokinetics of reduced folates after intraperitoneal and intravenous administration of racemic [6S,R]-folinic acidJ H Sips, O van Tellingen, W J Nooijen, et al.
Gut|December 1, 1995
Absence of ras gene mutations in early gastric carcinomasM E Craanen, P Blok, B Top, et al.
Breast Cancer Research and Treatment|November 26, 1999
Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence-based amplification for the detection of circulating breast cancer cellsA C Lambrechts, A J Bosma, S G Klaver, et al.
Pageof 19